

Author: Kiu Hiu Nicholson Sandra E.
Publisher: Informa Healthcare
ISSN: 0897-7194
Source: Growth Factors, Vol.30, Iss.2, 2012-04, pp. : 88-106
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Since its discovery two decades ago, the activation of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway by numerous cytokines and growth factors has resulted in it becoming one of the most well-studied intracellular signalling networks. The field has progressed from the identification of the individual components to high-resolution crystal structures of both JAK and STAT, and an understanding of the complexities of the molecular activation and deactivation cycle which results in a diverse, yet highly specific and regulated pattern of transcriptional responses. While there is still more to learn, we now appreciate how disruption and deregulation of this pathway can result in clinical disease and look forward to adoption of the next generation of JAK inhibitors in routine clinical treatment.
Related content


Biology and significance of signalling pathways activated by IGF-II
By Harris Lynda K. Westwood Melissa
Growth Factors, Vol. 30, Iss. 1, 2012-02 ,pp. :


Androgen Receptor Cross-talk with Cell Signalling Pathways
By Culig Zoran
Growth Factors, Vol. 22, Iss. 3, 2004-09 ,pp. :




Opposing actions of STAT-1 and STAT-3
By Stephanou A. Latchman D. S.
Growth Factors, Vol. 23, Iss. 3, 2005-09 ,pp. :


Cross-regulation of JAK and Src kinases
By Ingley Evan Klinken S. Peter
Growth Factors, Vol. 24, Iss. 1, 2006-03 ,pp. :